Patents by Inventor Alexander D'Addio

Alexander D'Addio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070219253
    Abstract: Compositions consisting essentially of phenylephrine tannate, pyrilamine tannate, and guaifenesin which are effective when administered orally for the symptomatic relief of cough and nasal congestion associated with respiratory tract conditions such as the common cold, bronchial asthma, acute and chronic bronchitis are disclosed.
    Type: Application
    Filed: September 17, 2003
    Publication date: September 20, 2007
    Inventors: Gul Balwani, Alexander D'Addio, Jeff Gazzara, Phuong Dang
  • Publication number: 20070020330
    Abstract: The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g.
    Type: Application
    Filed: July 14, 2006
    Publication date: January 25, 2007
    Applicant: MedPointe Healthcare Inc.
    Inventors: Phuong Dang, Brian Lawrence, Gul Balwani, Alexander D'Addio
  • Publication number: 20060110331
    Abstract: The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g.
    Type: Application
    Filed: November 22, 2005
    Publication date: May 25, 2006
    Applicant: MedPointe Healthcare Inc.
    Inventors: Phuong Dang, Brian Lawrence, Gul Balwani, Alexander D'Addio